14-day Premium Trial Subscription Try For FreeTry Free
$3.12
-0.0600 (-1.89%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $3.01 $5.59 Thursday, 2nd May 2024 NEXI stock ended at $3.12. This is 1.89% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 3.48% from a day low at $3.07 to a day high of $3.18.
90 days $3.01 $19.65
52 weeks $0.150 $28.69

Historical NexImmune, Inc. prices

Date Open High Low Close Volume
Apr 05, 2021 $20.65 $21.30 $19.06 $20.60 58 589
Apr 01, 2021 $19.56 $21.65 $18.76 $20.84 99 872
Mar 31, 2021 $18.30 $19.22 $18.15 $19.08 115 120
Mar 30, 2021 $18.52 $19.00 $17.48 $18.32 48 325
Mar 29, 2021 $20.20 $20.25 $18.59 $18.64 164 379
Mar 26, 2021 $19.38 $20.48 $19.38 $20.25 26 096
Mar 25, 2021 $17.77 $19.35 $17.76 $19.16 56 027
Mar 24, 2021 $18.10 $19.80 $17.77 $17.95 59 900
Mar 23, 2021 $19.01 $19.62 $17.76 $18.16 55 765
Mar 22, 2021 $19.30 $20.96 $19.13 $19.30 91 573
Mar 19, 2021 $20.72 $21.54 $18.00 $19.51 962 665
Mar 18, 2021 $20.00 $21.94 $19.79 $20.01 83 508
Mar 17, 2021 $21.22 $22.06 $19.50 $19.55 159 138
Mar 16, 2021 $22.36 $23.71 $21.50 $21.74 61 268
Mar 15, 2021 $24.73 $25.82 $22.26 $22.77 73 498
Mar 12, 2021 $22.91 $25.47 $22.69 $24.85 53 220
Mar 11, 2021 $21.52 $23.92 $19.76 $23.06 77 316
Mar 10, 2021 $22.31 $23.29 $19.55 $21.09 141 452
Mar 09, 2021 $20.75 $26.50 $20.59 $22.19 175 721
Mar 08, 2021 $18.74 $21.41 $18.48 $20.63 79 577
Mar 05, 2021 $20.45 $21.04 $18.03 $18.69 456 107
Mar 04, 2021 $23.27 $23.69 $17.06 $20.00 273 556
Mar 03, 2021 $23.15 $24.16 $22.32 $23.69 83 034
Mar 02, 2021 $24.35 $25.11 $22.29 $23.14 127 698
Mar 01, 2021 $24.96 $26.38 $23.07 $24.36 149 078
Click to get the best stock tips daily for free!

About NexImmune, Inc.

NexImmune. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f... NEXI Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT